- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 2 residues within 4Å:- Chain A: N.282, N.283
No protein-ligand interaction detected (PLIP)NAG.4: 5 residues within 4Å:- Chain A: P.1365, N.1366, S.1368, E.1369, K.1423
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.1423
NAG.5: 1 residues within 4Å:- Chain A: N.1375
No protein-ligand interaction detected (PLIP)NAG.31: 3 residues within 4Å:- Chain B: V.91, N.93, F.107
No protein-ligand interaction detected (PLIP)NAG.32: 3 residues within 4Å:- Chain B: G.33, T.109, N.110
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:G.33
NAG.33: 4 residues within 4Å:- Chain B: R.85, R.89, T.112, N.114
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.112
- Hydrogen bonds: B:N.114
- 2 x P0T: cannabidiol(Non-covalent)
P0T.6: 11 residues within 4Å:- Chain A: A.1313, L.1314, A.1317, I.1321, N.1459, F.1460, Q.1463, L.1749, N.1753, I.1756, L.1760
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.1314, A:A.1317, A:I.1321, A:F.1460, A:L.1749, A:L.1749, A:I.1756, A:I.1756, A:L.1760
P0T.7: 12 residues within 4Å:- Chain A: V.383, I.386, F.387, F.391, L.1651, F.1692, T.1695, T.1696, V.1751, M.1754
- Ligands: LPE.23, LPE.24
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:V.383, A:F.387, A:F.387, A:F.391, A:L.1651, A:F.1692, A:F.1692, A:T.1695, A:V.1751, A:V.1751
- 2 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.8: 13 residues within 4Å:- Chain A: W.1179, R.1182, Y.1186, L.1242, W.1245, I.1246, A.1247, Y.1248, G.1249, Y.1250, K.1251
- Ligands: LPE.27, LPE.28
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.1242, A:I.1246, A:Y.1250
- Hydrogen bonds: A:K.1251
- Salt bridges: A:R.1182, A:R.1182, A:K.1251
P5S.21: 13 residues within 4Å:- Chain A: L.388, G.1489, G.1577, W.1578, F.1581, L.1621, V.1624, R.1631, T.1632, L.1634, L.1637, M.1638
- Ligands: PCW.22
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:L.388, A:L.388, A:W.1578, A:W.1578, A:W.1578, A:F.1581, A:L.1621, A:V.1624, A:L.1634, A:L.1634, A:L.1637
- Hydrogen bonds: A:G.1489
- Salt bridges: A:R.1631
- 5 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.9: 2 residues within 4Å:- Chain A: A.1257, W.1260
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:A.1257, A:W.1260, A:W.1260, A:W.1260
Y01.10: 10 residues within 4Å:- Chain A: V.755, T.758, L.759, S.848, W.849, E.981, L.988, L.1326, I.1330, L.1333
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:V.755, A:V.755, A:T.758, A:L.759, A:W.849, A:W.849, A:W.849, A:L.988, A:L.1326, A:L.1333
Y01.12: 11 residues within 4Å:- Chain A: A.212, T.215, L.219, L.222, V.235, I.876, F.880, L.887, M.943, M.950, I.954
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:A.212, A:T.215, A:L.219, A:V.235, A:I.876, A:F.880, A:L.887, A:I.954
Y01.13: 2 residues within 4Å:- Chain A: Y.1432, V.1439
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Y.1432, A:Y.1432, A:V.1439
Y01.30: 9 residues within 4Å:- Chain A: A.762, H.765, P.767, L.1329, L.1333, N.1391
- Ligands: LPE.14, LPE.16, PCW.17
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.1329, A:L.1333
- Salt bridges: A:H.765
- 1 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
9Z9.11: 11 residues within 4Å:- Chain A: N.395, L.398, E.406, F.963, L.964, L.967, S.972, I.1453, I.1457, I.1759, F.1763
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.398, A:F.963, A:L.967, A:I.1453, A:I.1453, A:I.1457, A:I.1759, A:I.1759, A:F.1763
- Hydrogen bonds: A:E.406
- 13 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
LPE.14: 5 residues within 4Å:- Chain A: M.763, H.765, F.772
- Ligands: LPE.16, Y01.30
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:H.765
LPE.15: 8 residues within 4Å:- Chain A: P.1733, S.1734, I.1737, F.1738, V.1741, S.1742, I.1745
- Ligands: PCW.17
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.1737, A:F.1738, A:V.1741, A:I.1745
LPE.16: 3 residues within 4Å:- Ligands: LPE.14, PCW.17, Y01.30
No protein-ligand interaction detected (PLIP)LPE.18: 9 residues within 4Å:- Chain A: L.1295, L.1298, V.1311, Y.1658, F.1661, F.1738, Y.1739, I.1746
- Ligands: LPE.19
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.1311
- pi-Cation interactions: A:F.1661
LPE.19: 10 residues within 4Å:- Chain A: N.1256, A.1257, W.1258, L.1261, L.1292, L.1295, V.1311, N.1312, I.1315
- Ligands: LPE.18
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.1292, A:L.1295
LPE.23: 7 residues within 4Å:- Chain A: Q.1478, Y.1481, L.1641, F.1645, G.1648, L.1649
- Ligands: P0T.7
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.1649
- Salt bridges: A:E.1477
LPE.24: 7 residues within 4Å:- Chain A: T.319, D.320, K.376, M.379, L.1651, M.1655
- Ligands: P0T.7
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.1651
LPE.25: 6 residues within 4Å:- Chain A: G.1207, A.1210, F.1211, F.1304, F.1656, F.1684
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.1304, A:F.1656
- Hydrogen bonds: A:A.1210
LPE.26: 7 residues within 4Å:- Chain A: V.253, F.254, S.257, S.348, M.1533, A.1627
- Ligands: PCW.20
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.253
LPE.27: 6 residues within 4Å:- Chain A: W.1178, W.1179, R.1182, Y.1250
- Ligands: P5S.8, LPE.28
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.1182
LPE.28: 3 residues within 4Å:- Chain A: K.1251
- Ligands: P5S.8, LPE.27
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.1251
LPE.34: 5 residues within 4Å:- Chain B: V.175, M.178, I.179, Y.182, K.183
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:M.178
LPE.35: 6 residues within 4Å:- Chain A: F.1194, F.1197
- Chain B: W.173, L.174, E.177, C.181
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:E.177
- 4 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.17: 14 residues within 4Å:- Chain A: C.1328, L.1329, W.1332, N.1391, G.1393, L.1394, L.1397, L.1400, I.1737, V.1741, I.1745
- Ligands: LPE.15, LPE.16, Y01.30
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.1332, A:L.1394, A:L.1397, A:L.1400, A:I.1737, A:V.1741, A:I.1745
PCW.20: 12 residues within 4Å:- Chain A: Y.339, G.340, Y.341, S.348, W.349, F.351, F.355, Q.941, A.942, L.945, M.949
- Ligands: LPE.26
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:W.349, A:F.351, A:F.355, A:L.945, A:L.945, A:M.949
- Hydrogen bonds: A:S.348, A:Q.941
PCW.22: 7 residues within 4Å:- Chain A: L.1488, Q.1494, G.1577, F.1581, V.1584, L.1614
- Ligands: P5S.21
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.1581, A:V.1584, A:L.1614
- Hydrogen bonds: A:G.1577
PCW.29: 3 residues within 4Å:- Chain A: F.1574, V.1584, I.1587
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.1584, A:I.1587
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, J. et al., Cannabidiol inhibits Na v channels through two distinct binding sites. Nat Commun (2023)
- Release Date
- 2023-07-05
- Peptides
- Sodium channel protein type 9 subunit alpha: A
Sodium channel subunit beta-1: B
Sodium channel subunit beta-2: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x P0T: cannabidiol(Non-covalent)
- 2 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- 5 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 1 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
- 13 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 4 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, J. et al., Cannabidiol inhibits Na v channels through two distinct binding sites. Nat Commun (2023)
- Release Date
- 2023-07-05
- Peptides
- Sodium channel protein type 9 subunit alpha: A
Sodium channel subunit beta-1: B
Sodium channel subunit beta-2: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.